Lv1
28 积分 2023-12-27 加入
Atrasentan in Patients with IgA Nephropathy
13天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
13天前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
13天前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study
14天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
28天前
已完结
Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
Molecular Profiling Across 80,000 Patients With Lung Cancer
1个月前
已完结
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
